Abstract:The immune (innate and adaptive) system has evolved to protect the host from any danger present in the surrounding outer environment (microbes and associated MAMPs or PAMPs, xenobiotics, and allergens) and dangers originated within the host called danger or damage-associated molecular patterns (DAMPs) and recognizing and clearing the cells dying due to apoptosis. It also helps to lower the tissue damage during trauma and initiates the healing process. The pattern recognition receptors (PRRs) play a crucial role in recognizing different PAMPs or MAMPs and DAMPs to initiate the pro-inflammatory immune response to clear them. Toll-like receptors (TLRs) are first recognized PRRs and their discovery proved milestone in the field of immunology as it filled the gap between the first recognition of the pathogen by the immune system and the initiation of the appropriate immune response required to clear the infection by innate immune cells (macrophages, neutrophils, dendritic cells or DCs, and mast cells). However, in addition to their expression by innate immune cells and controlling their function, TLRs are also expressed by adaptive immune cells. We have identified 10 TLRs (TLR1-TLR10) in humans and 12 TLRs (TLR1-TLR13) in laboratory mice till date as TLR10 in mice is present only as a defective pseudogene. The present chapter starts with the introduction of innate immunity, timing of TLR evolution, and the evolution of adaptive immune system and its receptors (T cell receptors or TCRs and B cell receptors or BCRs). The next section describes the role of TLRs in the innate immune function and signaling involved in the generation of inflammation. The subsequent sections describe the expression and function of different TLRs in murine and human adaptive immune cells (B cells and different types of T cells, including CD4+T cells, CD8+T cells, CD4+CD25+Tregs, and CD8+CD25+Tregs, etc.). The modulation of TLRs expressed on T and B cells has a great potential to develop different vaccine candidates, adjuvants, immunotherapies to target various microbial infections, including current COVID-19 pandemic, cancers, and autoimmune and autoinflammatory diseases.

Toll-like Receptors as Versatile Regulators in the Nervous System

Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential

TLR Signaling in Brain Immunity.

TLR-Mediated Signal Transduction and Neurodegenerative Disorders

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems

Toll-like receptors in inflammation, infection and cancer

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors

Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases

The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management

Toll-like Receptors and the Control of Immunity

Toll-like Receptors in Innate Immunity and Infectious Diseases

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals

Toll like receptor - potential drug targets in infectious disease.

Toll-Like Receptor Signaling in the Establishment and Function of the Immune System

Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists

Toll-Like Receptors in Adaptive Immunity

Toll-like receptor control of the adaptive immune responses

Toll-like Receptors: Emerging Targets of Immunomodulation